Most Favored Nation Model for drug pricing to be introduced in USA in January

In support of US President Donald Trump's historic commitment to lowering drug prices for patients, Health and Human Services (HHS) Secretary Alex Azar announced a drug payment model through the Center for Medicare and Medicaid Innovation at the Centers for Medicare & Medicaid Services (CMS).

This system proposes to lower Medicare Part B payments for certain drugs to the lowest price for similar countries, thereby saving American taxpayers and beneficiaries more than $85 billion over seven years.